Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer. (2019)
Attributed to:
Improving earlier diagnosis and precision medicine for reduced mortality of breast cancer in Kenya
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41379-019-0270-4
PubMed Identifier: 30976105
Publication URI: http://europepmc.org/abstract/MED/30976105
Type: Journal Article/Review
Volume: 32
Parent Publication: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Issue: 9
ISSN: 0893-3952